116 results about "Transferase Gene" patented technology

The invention provides application of acidophilous glycosyltransferase in salidroside production, and belongs to the technical field of biological engineering. The problem of producing salidroside under the acidic condition is solved. Comprising an application of acidophilous glycosyl transferase with an amino acid sequence as shown in SEQ ID NO.1 in salidroside production under an acidic condition and an acidophilous escherichia coli engineering strain for producing salidroside. The escherichia coli engineering strain overexpresses a mutant 3-deoxy-D-arabinoheptulose-7-phosphate (DAHP) synthetase gene aroGfbr, a cyclohexadiene dehydrogenase gene tyrC, a glucose phosphate mutant enzyme gene pgm and a UDP-glucose pyrophosphorylase galU, overexpresses a phenylpyruvate decarboxylase gene ARO10 derived from saccharomyces cerevisiae, and can be used for producing a mutant 3-deoxy-D-arabinoheptulose-7-phosphate mutant enzyme. The kit comprises an ethanol dehydrogenase gene ADH6 and a glycosyl transferase gene LrUGT85AF8. The method is mainly used for producing salidroside under an acidic condition.

The invention relates to the technical field of gene engineering, in particular to a glycosyl transferase mutant and application thereof in synthesis of rebaudioside M. Wild type glycosyl transferase is modified through a directed evolution theory to obtain the glycosyl transferase mutant, so that the efficiency of synthesizing rebaudioside D through reaction of rebaudioside A is effectively improved. Besides, recombinant bacteria capable of simultaneously expressing the glycosyl transferase mutant, a second glycosyl transferase gene and a sucrose synthase gene are constructed, a wet cell obtained by induced culture of the recombinant bacteria or a crude enzyme liquid extracted by crushing the wet cell is used as a catalyst, rebaudioside A is used as a substrate, sucrose is used as an auxiliary substrate, and the rebaudioside M is catalytically synthesized by a one-pot method. According to the present invention, the complete catalysis of 100 g / L of rebaudioside A to produce rebaudioside M only needs 24 h, the conversion rate reaches 97.5%, the yield of rebaudioside M reaches 130 g / L, the raw material conversion rate and the yield of rebaudioside M are effectively improved, and the synthesis time is shortened.

The invention discloses a corynebacterium glutamicum engineering strain produced by L-glutamine as well as a construction method and application of the corynebacterium glutamicum engineering strain. The corynebacterium glutamicum engineering strain is prepared by integrating a glutamine synthase encoding gene glnA which is sourced from saccharomyces cerevisiae and has a tyrosine residue mutation at the 99th site on the surface and an sRNA-MicC-EcHfq regulation module of a targeted adenylyltransferase gene glnE into a vector plasmid; the method comprises the following steps: constructing a recombinant plasmid for removing adenosine acylation of glutamine synthase; and transferring the recombinant plasmid into corynebacterium glutamicum of which the odhA gene expression is controlled by a growth stage specific promoter Pcg2705, so as to obtain a corynebacterium glutamicum engineering strain for producing L-glutamine. According to the invention, through multi-gene synergistic modification and space-time metabolic flux optimization, the problem of'growth-synthesis' tradeoff in the prior art is solved, the fermentation efficiency is improved, the fermentation process is simple, and the application prospect is good.

The present application belongs to the technical field of genetic engineering, and particularly relates to a methyltransferase gene CmCMT2 and CmDRM2 application in regulating chrysanthemum flowering. The present application constructs an RNAi silencing expression vector by isolating CmCMT2 and CmDRM2 genes in a chrysanthemum variety "Jinma", and obtains CmCMT2 -RNAi and CmDRM2 -RNAi transgenic "Jinma" plants by using a genetic transformation method, then performs phenotype observation and statistics on the transgenic plants, and explores CmCMT2 and CmDRM2 the mechanism of the genes affecting early flowering of chrysanthemum by using an RNA-seq method. The CmCMT2 and CmDRM2 genes are cloned from the chrysanthemum variety "Jinma", and spatiotemporal expression analysis shows that CmCMT2 and CmDRM2 the genes are highly expressed during the process of "Jinma" from bud development to color change; and CmCMT2 and CmDRM2 the expression level in leaves gradually decreases during the growth and development of "Jinma". The research results show that CmCMT2 and CmDRM2 the content of GA1 is changed by negatively regulating the expression of CmG20ox2a and CmG20ox2b , so that the flowering period of chrysanthemum is advanced by 15 and 8 days, respectively.

The invention discloses an ergothioneine-producing recombinant engineering bacterium as well as a construction method and application thereof, and belongs to the technical field of gene recombination fermentation. The method comprises the following steps: by taking escherichia coli as a starting bacterium, carrying out recombinant expression on a histidine trimethyl inner salt cysteine sulfoxide synthetase egt1 gene, an L-histidine methyltransferase egtD gene, a histidine trimethyl inner salt cysteine sulfoxide lyase egt2 gene, a methionine adenosine transferase metK gene, an adenylate kinase adK gene and an adenine phosphoribose transferase apt gene; on this basis, supply of precursor substances including histidine, cysteine and methionine is further improved through metabolic transformation, the yield of the finally obtained recombinant engineering bacterium for producing ergothioneine reaches 2.54 g / L after 48 h of shake-flask culture, the yield of a 5L fermentation tank reaches 18 g / L after further enlarged culture, the yield of ergothioneine is guaranteed while energy consumption and cost are reduced, and the method is suitable for industrial production. The method is suitable for practical popularization.

The application belongs to the technical field of biology and relates to a Clostridium butyricum engineering strain for improving butyric acid synthesis through a coenzyme A transferase pathway as well as a construction method and application of the Clostridium butyricum engineering strain. Clostridium tyrobutyricum The application expresses a butyryl coenzyme A:acetic acid-coenzyme A transferase gene from Clostridium tyrobutyricum Ctcat1 A coenzyme A transferase (CoAT) pathway is constructed, the pathway synthesizes butyric acid by taking acetic acid as a substrate, therefore, the content of acetic acid in a fermentation product is greatly reduced, and the butyric acid yield is significantly improved.

The invention provides glycosyl transferase and application thereof in preparation of salidroside, and relates to the technical field of enzyme engineering. The glycosyl transferase FpUGT provided by the invention is derived from fraxinus pennsylvanica, the existence of the glycosyl transferase gene capable of directly catalytically synthesizing the salidroside in the plant is not reported in literatures, and a new biological way is provided for finding the glycosyl transferase for efficiently synthesizing the salidroside. And a new biological material is provided for preparing the salidroside.

This invention provides a chalcone isopentenyltransferase gene. GiPT16 This invention relates to the GiPT16 protein, amplification primer set, and applications, belonging to the field of biogenetics technology. It is based on *Glycyrrhiza inflata* (GiPT16 protein, amplification primer set, and applications). Glycyrrhiza inflata Using whole-genome sequencing data and a reverse genetics strategy, the key aromatic isopentenyltransferase GiPT16, involved in the isopentenylation modification of chalcone active ingredients, was successfully identified and functionally characterized. This enzyme was confirmed to specifically catalyze the biosynthesis of psoralen and glycyrrhizin C using DMAPP as a donor. It is the first chalcone isopentenyltransferase characterized in *Glycyrrhiza inflata*, filling a gap in the study of key enzymes in the chalcone isopentenylation metabolic pathway of this species and providing important evidence for further elucidating the molecular mechanisms of quality formation in *Glycyrrhiza inflata* medicinal materials.

The present invention belongs to the field of plant genetic engineering technology, and in particular to the application of a Centella asiatica glycosyltransferase gene in catalyzing the glycosylation of asiatic acid and madecassic acid. The nucleotide sequence of the gene is as shown in SEQ ID No.1, and the protein encoded by it can catalyze the C-28 position of asiatic acid and madecassic acid to carry out glucose group modification to produce asiatic acid monoglucoside and madecassic acid monoglucoside, and prefers catalysis madecassic acid. The present invention, by building a metabolic regulatory network, widely and accurately screens the above-mentioned gene, resolves the glycosylation process of catalyzing asiatic acid and madecassic acid, for the in vitro synthesis of Centella asiatica triterpenoid saponins and industrial production process to improve asiatic acid and madecassic acid glycosylation efficiency and asiaticoside and madecassin yield provide important reference basis, and provide important theoretical support for large-scale production of Centella asiatica active saponins.

The invention belongs to the technical field of biology, and relates to a clostridium butyricum engineering strain for improving butyric acid synthesis through a coenzyme A transferase pathway, and a construction method and application thereof. According to the method disclosed by the invention, a coenzyme A transferase (CoAT) pathway is constructed by expressing butyryl coenzyme A: acetic acid-coenzyme A transferase gene Ctcat1 from clostridium tyrobutyricum, and the pathway is used for synthesizing butyric acid by taking acetic acid as a substrate, so that the content of acetic acid in a fermentation product is greatly reduced, and the yield of butyric acid is remarkably increased.

The application provides a kind of aromatic isopentenyl transferase mutant, which is based on the aromatic isopentenyl transferase gene MenA derived from Bacillus subtilis ( Bacillus subtilis ) and six aromatic isopentenyl transferase mutants MenA-1 to MenA-6 are obtained by site-directed mutagenesis PCR technology, and the recombinant bacteria Bacillus subtilis expressing the above mutants are constructed, respectively. The yield of heptamethylnaphthoquinone fermented by the recombinant bacteria is 64.49 mg / L, 69.30 mg / L, 83.86 mg / L, 105.84 mg / L, 119.23 mg / L and 125.45 mg / L, respectively, which is 133%, 143%, 173%, 219%, 246% and 259% of the yield of heptamethylnaphthoquinone fermented by the Bacillus subtilis expressing the wild-type aromatic isopentenyl transferase MenA.

This invention belongs to the field of biotechnology and discloses a recombinant strain of Saccharomyces cerevisiae that enhances the efficient synthesis of vitamin K2 and its application. By heterologously integrating the hepS / T and naphthoquinone cyclotransferase genes (menA) of Bacillus subtilis, four genetically engineered strains were constructed based on the designed MK-7 biosynthetic pathway: YK-1, YK-2, YK-3, and YK-4. YK-1 is an expression strain containing the target genes MenF, MenD, and MenH; YK-2 is an expression strain integrating the target genes MenC, MenE, and MenB on the basis of YK-1; YK-3 is an expression strain integrating the target genes hepS and hepT on the basis of YK-2; and YK-4 is an expression strain integrating the target genes yuxO, MenA, and MenG on the basis of YK-3. YK-4 is the final engineered strain that produces high levels of vitamin K2. The optimal fermentation time was determined by measuring OD600 and yield curves. YK-4 reached its maximum cell concentration in 18 hours, which can effectively shorten the fermentation cycle.

The invention discloses a genetically engineered bacterium for synthesizing N-acetyl blue as well as a construction method and application of the genetically engineered bacterium. The genetically engineered bacterium is prepared by knocking out a lactic dehydrogenase gene ldh and inserting a phosphoketolase gene xfpK on a knockout site, knocking out a pyruvate oxidase gene poxB and inserting a phosphate transacetylase gene pta on a knockout site of a microorganism for producing N-acetyl blue, and knocking out an aconitase inhibition factor gene acnR, inserting a glutamate dehydrogenase gene gdhA on a knockout site, knocking out a glutamine synthetase adenylation transferase gene glnE, and inserting an alpha-ketoglutarate dehydrogenase inhibition factor gene odhI on a knockout site to obtain the strain. According to the method, the supply of the precursor acetyl coenzyme A is enhanced by introducing a non-oxidative glycolysis pathway, the pH dynamic regulation system balances the metabolic flux, and the double breakthrough of the yield and the carbon recovery rate of the N-acetyl blue is realized by combining a two-stage fermentation process.

This invention belongs to the fields of fermentation and genetic engineering technology, and provides a high-yield hexanoic acid-producing engineered *Escherichia coli* strain, its construction method, and its applications. This engineered strain is *Escherichia coli*... E. coli w3110 was the starting strain, overexpressing the acetyl-CoA transferase gene. act and β-ketothiolase gene bktB Overexpression of trans-enoyl-CoA reductase gene ter 3-Hydroxybutyryl-CoA dehydrogenase gene hbd, and 3-hydroxybutyryl coenzyme A dehydratase gene crt Or, simultaneously not expressing the pyruvate formate lyase gene. pflB or lactate dehydrogenase gene ldhA This engineered bacteria can convert glucose into hexanoic acid, a high-value product, with a yield of 4.968 g / L after 18 hours of fermentation. It adopts aerobic fermentation, resulting in rapid cell growth, a short fermentation cycle, and a high acid production rate. The fermentation process is simple, easy to control, and has low production costs, which is conducive to its promotion and application in industrial production.

The invention discloses genetically engineered corynebacterium glutamicum and an application of the genetically engineered corynebacterium glutamicum in preparation of ectoine, and the genetically engineered corynebacterium glutamicum contains an L-diaminobutyric acid transaminase gene ectB, an L-diaminobutyric acid acetyltransferase gene ectA and an ectoine synthetase gene ectC, the invention relates to an aspartic acid transferase gene aspB, an aspartic acid kinase gene lysC and an aspartic acid semialdehyde dehydrogenase gene asd, wherein the nucleotide sequences of the gene aspB, the gene lysC and the gene asd are respectively as shown in SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6. The invention further discloses a preparation method of the aspartic acid transferase gene aspB, the aspartic acid kinase gene lysC and the aspartic acid semialdehyde dehydrogenase gene asd. After the recombinant corynebacterium glutamicum constructed by the invention is fermented for 60 hours, the yield of ectoine can reach 50g / L. The genetically engineered corynebacterium glutamicum disclosed by the invention has important practical significance on industrial production and large-scale application of ectoine.

The invention discloses a recombinant bacterium for producing mevalonic acid by taking glucose and acetone as co-substrates as well as a construction method and application of the recombinant bacterium, and belongs to the technical field of genetic engineering. The problems that an existing mevalonic acid biosynthesis mode is low in carbon atom economy, limited in theoretical yield and the like are solved. According to the invention, acetone carboxylase, acetoacetyl coenzyme A synthetase, 3-hydroxy-3-methylglutaryl coenzyme A reductase and hydroxymethyl glutaryl-CoA synthetase are subjected to heterologous expression in escherichia coli with an acetyl coenzyme A acetyltransferase gene atoB and a histidine protein kinase gene atoS knocked out, and self carbonic anhydrase is over-expressed; and a new way for synthesizing MVA by using glucose and acetone as a co-substrate is constructed. According to the method, one molecule of CO2 can be fixed in the biosynthesis of mevalonic acid, the yield of carbon atoms in the synthesis process of mevalonic acid is increased, the problem of low yield of carbon atoms in the synthesis process of mevalonic acid by taking glucose as a single substrate is solved, and a new thought is provided for constructing a carbon neutralization type biological manufacturing technology.

The invention belongs to the technical field of biology, and particularly relates to flavonoid glycosyl transferase and application thereof. The invention relates to a flavonoid glycosyl transferase gene, wherein the nucleotide sequence of the flavonoid glycosyl transferase gene is shown as SEQ ID NO. 1. By focusing the rice drought resistance related gene and predicting and coding the flavonoid glycosyl transferase, through corresponding experiments, key biochemical evidences are provided for clarification of a molecular mechanism of the rice drought resistance related gene in drought response, a foundation is laid for analysis of a mechanism of glycosylation modification regulation and control of rice drought resistance, and the application of the flavonoid glycosyl transferase to rice drought resistance regulation and control is developed. The method has important theoretical value and application potential for crop stress resistance genetic improvement.

The invention relates to a method for preparing irisflorentin by utilizing belamcandin, and belongs to the technical field of biology. The method comprises the following steps: carrying out C-5 site and C-3'site methylation reaction by taking white belamcandin as a substrate, taking belamcanda methyl transferase gene BcOMT03 gene encoding protein and belamcanda methyl transferase BcOMT33 gene encoding protein as catalysts and taking S-adenosine-methionine as a methyl donor to generate a corresponding glycosylation product. According to the invention, the functions of the two methyltransferase genes BcOMT03 and BcOMT33 in the blackberry lily are identified and verified for the first time, the effect of the two methyltransferase genes BcOMT03 and BcOMT33 in catalyzing the ibullamcandin to produce the irisflorentin is defined, and the blank of research on the biosynthetic pathway of the characteristic component irisflorentin of the blackberry lily is filled up; important information is provided for research on a biosynthesis mechanism of active ingredients of medicinal plants.

The present specification discloses a method for producing a peptide such as glutathione, and a microorganism that can be used by the method. One or more embodiments of a first aspect pertain to a method for producing a peptide such as glutathione, the method comprising culturing a prokaryotic microorganism strain in which the expression level of one or more genes selected from the group consisting of gshA genes, gshB genes, and gshF genes has been increased than that of a wild strain in a culture medium in which the total concentration of cysteine and cystine is 0.5 g / L or less. The second aspect relates to a microorganism in which the gamma-glutamyltransferase gene and the glutathione reductase gene are deleted and the expression of the gshA gene and the gshB, or gshF gene is enhanced.

The application belongs to the technical field of genetic engineering, and discloses a kind of synthetic lactosyl-N-neotetraose and safe recombinant bacillus subtilis and its construction method and application, the recombinant bacillus subtilis is obtained by transforming plasmid containing beta-1,3-N-acetylglucosamine transferase, beta-1,4-galactosyltransferase gene and lactose permease gene in bacillus subtilis 168.The application aims at the huge demand of lactosyl-N-neotetraose in the market in prior art, and the lactosyl-N-neotetraose produced by most existing engineering bacteria is not safe, provides an engineering bacteria for producing lactosyl-N-neotetraose and application, to meet the demand of lactosyl-N-tetraose in the market.

The application belongs to the technical field of genetic engineering and enzyme engineering, and discloses a dragon blood tree flavone compound O-methyltransferase gene and application thereof. Three functionally differentiated O-methyltransferase genes DcOMT1, DcOMT2 and DcOMT3 are cloned from dragon blood tree, and the coded proteins can catalyze O-methylation reaction of flavonoids. The three enzymes show different catalytic modes for dracorhodin D: DcOMT1 preferentially catalyzes 4,4'-dihydroxy-2,6-dimethoxydihydrochalcone to generate dracorhodin B and further catalyzes dracorhodin B; DcOMT2 catalyzes dracorhodin B; and DcOMT3 catalyzes 4,4'-dihydroxy-2,6-dimethoxydihydrochalcone. The functions of the three enzymes are complementary, and can be used alone or in combination to realize precise synthesis of multiple different methylated flavones from a single substrate.

The invention relates to the field of plant genetic engineering, in particular to application of ginseng glycosyl transferase UGT84K2 to improvement of abiotic stress resistance of plants. The ginseng glycosyl transferase UGT84K2 gene is transferred into a model plant arabidopsis thaliana for research, an overexpression strain of the ginseng glycosyl transferase UGT84K2 is constructed, salt-resistant and drought-resistant adversity stress treatment is performed, and results show that under the conditions of adversity high salt (NaCl), drought stress (osmotic stress) and the like, the expression quantity of the ginseng glycosyl transferase UGT84K2 is up-regulated, and the expression quantity of the ginseng glycosyl transferase UGT84K2 is up-regulated. And the ginseng glycosyl transferase UGT84K2 overexpression strain shows stronger tolerance under the adverse condition, which reflects that the stress resistance of the ginseng glycosyl transferase UGT84K2 overexpression strain can be enhanced through glycosylation modification.

The invention belongs to the technical field of genetic engineering, and discloses a genetically engineered bacterium for efficiently synthesizing gamma-aminobutyric acid from the beginning by efficiently utilizing a mixed carbon source, a method and application, and the genetically engineered bacterium is obtained by overexpressing edd from Zymomonas mobilis on the basis of escherichia coli E. coli G16; eda from the zymomonas mobilis is over-expressed; performing overexpression on acs (Acetobacter pasteurianus) sources; a malic acid synthase gene aceB is knocked out; a malic acid synthase gene glcB is knocked out; and the acetyl phosphate transferase gene eutD is knocked out. The escherichia coli strain which is clear in genetic background and capable of producing gamma-aminobutyric acid is utilized, and an ED path and an acetic acid utilization path are introduced, so that acetyl CoA branch metabolism is reduced, and the yield and conversion rate of gamma-aminobutyric acid are remarkably improved.

The invention discloses application of an epiregulatory factor gene in regulation of plant heat resistance. The epiregulatory factor gene (TaMET) is identified from a wheat genome for the first time. The gene is subjected to transient overexpression in wheat Fielder, and it is found that wheat can be more sensitive to heat expression. The homologous gene (OsMET) of the gene in rice is subjected to conservative structural domain analysis to find that the gene is an SAM dependent type methylated transferase gene, and the modification level of histone H3K27me3 can be influenced. Research finds that overexpression of the gene makes the plant more sensitive to heat, knockout of the gene can significantly improve the heat resistance of rice Nipponbare, that is, the gene belongs to a negative regulation factor of rice heat resistance, for example, deep analysis of a mechanism of the gene or a homologous gene thereof is beneficial to excavation of heat-resistant genes in rice and wheat.

The application discloses a branched-chain amino acid aminotransferase gene RkBat2 , wherein the nucleotide sequence is shown as SEQ ID NO:1, the amino acid sequence coded by the gene is shown as SEQ ID NO:2, and the gene is obtained from Rhodosporidium diobovatum YM25235, and the gene is transformed into the Rhodosporidium diobovatum YM25235 through transformation. Rhodosporidium kratochvilovae Experimental results show that overexpression of the gene RkBat2 can cause the improvement of the carotenoid synthesis level in the YM25235 strain; the application improves the carotenoid yield in microorganisms through genetic engineering, and lays a foundation for large-scale commercial production of carotenoids.

This invention belongs to the field of plant biocontrol. Specifically, this invention provides the application of the rice RNA adenine methyltransferase EDM2L gene in regulating plant antiviral resistance. This was achieved by comparing rice plants inoculated with RSV virus. edm2l Knockout mutants and edm2l' Analysis of methyltransferase catalytic activity mutants and ZH11 wild plants revealed that knockout edm2l Downregulation of EDM2L expression significantly weakens rice's resistance to RSV, indicating that this gene has an anti-RSV function. This invention provides a new target gene locus for cultivating crops with enhanced virus resistance using genetic engineering techniques, and has significant implications and broad application prospects in regulating plant resistance and disease-resistant breeding.

The application belongs to the technical field of biology and particularly relates to a flavonoid glycosyltransferase and application thereof. A flavonoid glycosyltransferase gene, wherein the nucleotide sequence of the flavonoid glycosyltransferase gene is shown as SEQ ID NO. 1. The application focuses on drought-resistant related genes of rice, predicts that a flavonoid glycosyltransferase is coded, and through corresponding experiments, not only provides key biochemical evidence for elucidating the molecular mechanism of drought-resistant related genes of rice in drought response, but also lays a foundation for analyzing the mechanism of glycosylation modification regulating drought resistance of rice, has important theoretical value and application potential for genetic improvement of crop stress resistance.

The present invention discloses a genetically engineered Schizochytrium strain for efficient DHA production, as well as a construction method and application. The genetically engineered strain is obtained by knocking out the peroxisome matrix protein gene PEX10 in the wild-type Schizochytrium, which disrupts the β-oxidation pathway and blocks the degradation of fatty acyl-CoA; overexpressing the acetyl-CoA carboxylase gene ACC1 to provide more malonyl-CoA precursors, thereby promoting fatty acid biosynthesis; and overexpressing the diacylglycerol acyltransferase gene DGAT to promote the accumulation of fatty acids in the form of triglycerides. Under shake flask conditions, after fermentation, the DHA and PUFA produced reached 55.10% and 70.47% of the total oil content, respectively. Compared with the wild-type strain, DHA and PUFA increased by 21.6% and 24.77%, respectively, without a significant change in biomass, showing extremely high application potential.

The invention relates to application of cyanobacteria acetyltransferase in increasing the content of astaxanthin in escherichia coli for producing astaxanthin, and also provides a method for increasing the content of astaxanthin in escherichia coli for producing astaxanthin, which comprises the step of introducing a cyanobacteria acetyltransferase gene expression cassette into escherichia coli. The method comprises the following steps: amplifying a target gene cKAT from a genome of blue-green algae, inserting the cKAT into an escherichia coli expression vector by using a recombinant DNA technology, and transforming the constructed expression vector into an escherichia coli BW-ASTA strain to obtain recombinant escherichia coli. Therefore, the content of the astaxanthin in the escherichia coli is increased by about 4 times, and a novel efficient, stable and large-scale microbial synthesis scheme is provided for greatly reducing the production cost of the astaxanthin.

The invention provides a co-expression vector and a method for changing the type of biosynthetic anthocyanin glycoside, and belongs to the technical field of genetic engineering. The invention provides a co-expression vector containing a gene overexpression box and a gene knockout box, and an MYB transcription factor overexpression box and an anthocyanin rhamnoside transferase gene knockout box are jointly constructed on a basic skeleton vector. Therefore, the co-expression vector can simultaneously achieve the effects of overexpressing MYB and knocking out the anthocyanin rhamnoside transferase gene. In the embodiment of the invention, by taking antirhubarb as an example, genetic transformation is completed by utilizing the co-expression vector, and gene knockout and overexpression are carried out through one vector, so that the conversion of anthocyanin from rhamnoside to glucoside is realized, for example, the conversion of cyanidin rhamnoside to cyanidin glucoside is realized, and the conversion of anthocyanin from rhamnoside to cyanidin glucoside is realized. Therefore, the content of glucoside in the anthocyanin glycoside is obviously improved.